Blog Viewer

Effects of Clazosentan on Cerebral Vasospasm–Related Morbidity and All-Cause Mortality after Aneurysmal Subarachnoid Hemorrhage: Two Randomized Phase 3 Trials in Japanese Patients

By Currents Editor posted 05-27-2022 16:44

  

Effects of Clazosentan on Cerebral Vasospasm–Related Morbidity and All-Cause Mortality after Aneurysmal Subarachnoid Hemorrhage: Two Randomized Phase 3 Trials in Japanese Patients
Journal of Neurosurgery (04/01/22) DOI: 10.3171/2022.2.JNS212914
Endo, Hidenori; Hagihara, Yasushi; Kimura, Naoto; et al.
https://thejns.org/view/journals/j-neurosurg/aop/article-10.3171-2022.2.JNS212914/article-10.3171-2022.2.JNS212914.xml 

New research out of Japan indicates that clazosentan led to significant reductions in the incidence of vasospasm-related morbidity and all-cause morbidity following aneurysmal subarachnoid hemorrhage (aSAH). Investigators conducted two similar Phase 3 studies in patients with aSAH, after their aneurysms were secured by endovascular coiling in one study and by surgical clipping in the second. Patients in each study were randomized to receive intravenous clazosentan (10 mg/hr) or placebo beginning within 48 hours of aSAH and for up to 15 days afterward. A total of 220 patients were included in the full analysis set of the primary analysis for each study, with 109 in each clazosentan group and 111 in each placebo group). After aneurysm coiling, the incidence of vasospasm-related morbidity and all-cause mortality dropped from 28.8% to 13.6% with clazosentan, while the rate after surgical clipping decreased from 39.6% to 16.2%. Clazosentan also resulted in significant reductions in all-cause morbidity/mortality and poor outcome after preplanned study pooling. There were no new safety concerns, as any treatment-emergent adverse events were similar to ones previously reported.

#LiteratureWatch

FURTHER READING
Michelle Schober, MD, MS Audrey Paulson, DNP, FNP-BC, CCRN, CNRN, SCRN Ethical principles common to the various health care professions include the concepts of justice, nonmaleficence, beneficence, and autonomy. The American Nurses Association (ANA) Code contains these concepts and cites three additional ...
New England Journal of Medicine (10/20/22) DOI: 10.1056/NEJMoa2208687 Kjaergaard, Jesper; Møller, Jacob E.; Schmidt, Henrik; et al. https://www.nejm.org/doi/full/10.1056/NEJMoa2208687 For patients who had been resuscitated from cardiac arrest, targeting a mean arterial blood pressure of 77 mm Hg ...
By Sarah Livesay, DNP, APRN Associate Dean, Rush University, President NCS Mary Kay Bader, RN, MSN, Neurocritical Care CNS, Mission Hospital Mission Viejo CA, Past President NCS Karen Hirsch MD, Associate Professor of Neurology, Division Chief Neurocriticial Care, Stanford University Romer Geocadin ...